Artemis Entreri

[Artemis Entreri @Entretis1]

@ej23ny Thank you as always.

[Artemis Entreri @Entretis1]

@ej23ny Thank you. I was feeling disappointed because they’ve been saying that they had enough cash to finish the ongoing trials.

[Artemis Entreri @Entretis1]

@ej23ny @Biotech2051 Thank you very much!

[Artemis Entreri @Entretis1]

@ej23ny @Biotech2051 https://t.co/K0VP1RD9xT

[Artemis Entreri @Entretis1]

@bob4punk Someone posted on Stocktwits board.

[Artemis Entreri @Entretis1]

@bob4punk They deleted this one.

[Artemis Entreri @Entretis1]

@bkfViking123 @cover_drive07 @COILPOD Notably, we head into ASH with a series of milestones expected for year-end and next year in addition to a strong cash position of $48 million at the end of the third quarter that will allow us to meet our development objectives well into 2022.

https://t.co/gMgwHVDuQr

[Artemis Entreri @Entretis1]

@Bu_LLss Why? Are they presenting new info or updates?

[Artemis Entreri @Entretis1]

@RamsCharts Thank you. I was wondering if I should load up now or wait.

[Artemis Entreri @Entretis1]

@MarcDeCock5 What did @biggercapital call?

[Artemis Entreri @Entretis1]

@ej23ny @ActiniumPharma I hope you are right. Another PO will put me on medication.

[Artemis Entreri @Entretis1]

@ej23ny Do you think they need to raise more capital for the new study?

[Artemis Entreri @Entretis1]

@bob4punk Well, I don’t know anything about Ktov, but I believe in the science and pipeline of Atnm. I’m going to ride it out.

[Artemis Entreri @Entretis1]

$ATNM

[Artemis Entreri @Entretis1]

@ej23ny I think we are going to be at $11.35, so I’m not sure why they didn’t go with 20 or even 15.

[Artemis Entreri @Entretis1]

@ej23ny What do you think about the 1 to 30 rs? I was hoping for less. I’m littled bummed out.

[Artemis Entreri @Entretis1]

@vtitarev Didn’t you say $150.50 in your earlier post?